JP2015510928A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510928A5 JP2015510928A5 JP2015501754A JP2015501754A JP2015510928A5 JP 2015510928 A5 JP2015510928 A5 JP 2015510928A5 JP 2015501754 A JP2015501754 A JP 2015501754A JP 2015501754 A JP2015501754 A JP 2015501754A JP 2015510928 A5 JP2015510928 A5 JP 2015510928A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- formulated
- analgesics
- release
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 238000000034 method Methods 0.000 claims 12
- 229940035676 analgesics Drugs 0.000 claims 8
- 239000000730 antalgic agent Substances 0.000 claims 8
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 7
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 claims 7
- 229960001475 zolpidem Drugs 0.000 claims 7
- 239000004480 active ingredient Substances 0.000 claims 6
- 230000003111 delayed effect Effects 0.000 claims 5
- 238000013265 extended release Methods 0.000 claims 5
- 229940124538 antidiuretic agent Drugs 0.000 claims 3
- 239000003160 antidiuretic agent Substances 0.000 claims 3
- 229940124575 antispasmodic agent Drugs 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000000812 cholinergic antagonist Substances 0.000 claims 3
- 239000003149 muscarinic antagonist Substances 0.000 claims 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 2
- 108030001720 Bontoxilysin Proteins 0.000 claims 2
- 229940053031 botulinum toxin Drugs 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- 230000027939 micturition Effects 0.000 claims 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 claims 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 229960004270 nabumetone Drugs 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- 229960003940 naproxen sodium Drugs 0.000 claims 1
- CDBRNDSHEYLDJV-FVGYRXGTSA-M naproxen sodium Chemical compound [Na+].C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CDBRNDSHEYLDJV-FVGYRXGTSA-M 0.000 claims 1
- 229960005489 paracetamol Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/424,000 US8236857B2 (en) | 2010-07-08 | 2012-03-19 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US13/424,000 | 2012-03-19 | ||
| US13/487,348 US20120244221A1 (en) | 2010-07-08 | 2012-06-04 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US13/487,348 | 2012-06-04 | ||
| PCT/US2013/030901 WO2013142197A1 (en) | 2012-03-19 | 2013-03-13 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017179685A Division JP2018024693A (ja) | 2012-03-19 | 2017-09-20 | 排尿頻度を減少させるための延長放出製剤およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015510928A JP2015510928A (ja) | 2015-04-13 |
| JP2015510928A5 true JP2015510928A5 (enExample) | 2016-03-24 |
Family
ID=49223209
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501754A Pending JP2015510928A (ja) | 2012-03-19 | 2013-03-13 | 排尿頻度を減少させるための延長放出製剤およびその使用方法 |
| JP2015501785A Pending JP2015510936A (ja) | 2012-03-19 | 2013-03-14 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
| JP2016092868A Pending JP2016172752A (ja) | 2012-03-19 | 2016-05-04 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
| JP2017179685A Pending JP2018024693A (ja) | 2012-03-19 | 2017-09-20 | 排尿頻度を減少させるための延長放出製剤およびその使用方法 |
| JP2018093416A Pending JP2018138602A (ja) | 2012-03-19 | 2018-05-15 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501785A Pending JP2015510936A (ja) | 2012-03-19 | 2013-03-14 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
| JP2016092868A Pending JP2016172752A (ja) | 2012-03-19 | 2016-05-04 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
| JP2017179685A Pending JP2018024693A (ja) | 2012-03-19 | 2017-09-20 | 排尿頻度を減少させるための延長放出製剤およびその使用方法 |
| JP2018093416A Pending JP2018138602A (ja) | 2012-03-19 | 2018-05-15 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP2827852A4 (enExample) |
| JP (5) | JP2015510928A (enExample) |
| KR (4) | KR20140134333A (enExample) |
| CN (4) | CN104302284A (enExample) |
| AU (4) | AU2013235518B2 (enExample) |
| BR (2) | BR112014020271A8 (enExample) |
| CA (2) | CA2866853A1 (enExample) |
| HK (3) | HK1204553A1 (enExample) |
| MX (3) | MX2014011128A (enExample) |
| MY (2) | MY174090A (enExample) |
| NZ (6) | NZ630471A (enExample) |
| RU (3) | RU2669565C2 (enExample) |
| SG (2) | SG11201500408VA (enExample) |
| WO (2) | WO2013142197A1 (enExample) |
| ZA (2) | ZA201405862B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10596127B2 (en) | 2013-03-14 | 2020-03-24 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
| DK3024474T3 (da) | 2013-07-23 | 2022-03-28 | Serenity Pharmaceuticals Llc | Sammensætninger omfattende desmopressin i kombination med en beta-3-adrenoreceptor-agonist |
| SG11201610383YA (en) * | 2014-06-06 | 2017-02-27 | Wellesley Pharmaceuticals Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| KR101809908B1 (ko) * | 2014-07-21 | 2018-01-25 | 주식회사 종근당 | 5-알파환원효소억제제를 포함하는 조성물 |
| EP3220942B1 (en) * | 2014-11-20 | 2022-04-27 | Serenity Pharmaceuticals LLC | Compositions comprising low dose desmopressin in combination with an alpha-adrenergic receptor antagonist |
| WO2017058428A1 (en) * | 2015-09-30 | 2017-04-06 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
| SG11201805527QA (en) * | 2015-09-30 | 2018-07-30 | Wellesley Pharmaceuticals Llc | Composition for reducing the frequency of urination, method of making and use thereof |
| CN105238124B (zh) * | 2015-11-16 | 2018-02-09 | 太仓东能环保设备有限公司 | 一种抗菌腻子粉 |
| JP6294924B2 (ja) | 2016-09-05 | 2018-03-14 | 株式会社Ｓｕｂａｒｕ | 車両の走行制御装置 |
| JP2019031556A (ja) * | 2018-10-31 | 2019-02-28 | ウェルズリー ファーマスーティカルズ、エルエルシー | 排尿頻度を減少させるための医薬製剤およびその使用の方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2320193A1 (en) * | 1998-02-10 | 1999-08-19 | Welfide Corporation | Controlled release preparation |
| US20020102309A1 (en) * | 1999-09-14 | 2002-08-01 | Jane C. I. Hirsh | Controlled release formulation for administration of an anti-inflammatory naphthalene derivative |
| DE10116978A1 (de) * | 2001-04-05 | 2002-10-10 | Merck Patent Gmbh | Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase |
| US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| WO2003070233A1 (en) * | 2002-02-19 | 2003-08-28 | Pharmacia Corporation | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| CA2487899A1 (en) * | 2002-06-07 | 2003-12-18 | Yamanouchi Pharmaceutical Co., Ltd. | Overactive bladder treating drug |
| US20040054008A1 (en) * | 2002-09-13 | 2004-03-18 | Tohru Araki | Medicament for treatment of nocturia |
| EP1492519B1 (en) * | 2003-03-21 | 2006-11-15 | Dynogen Pharmaceuticals, Inc. | Methods for treating lower urinary tract disorders using antimuscarinics and alpha-2-delta subunit calcium channel modulators |
| JP2006514982A (ja) * | 2003-03-21 | 2006-05-18 | マクニール−ピーピーシー・インコーポレイテッド | 非ステロイド抗炎症薬投薬計画 |
| EP1627876A1 (en) * | 2004-08-20 | 2006-02-22 | Ferring B.V. | Heterocyclic condensed compounds useful as antidiuretic agents |
| EP2248524A3 (en) * | 2004-08-25 | 2011-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| MX2007016307A (es) * | 2005-06-17 | 2008-03-05 | Dynamis Therapeutics Inc | Tratamiento de condiciones inflamatorias. |
| US20080085314A1 (en) * | 2005-07-29 | 2008-04-10 | Shalaby Shalaby W | Solid oral formulations for combination therapy |
| KR101054248B1 (ko) * | 2005-09-02 | 2011-08-08 | 테라비다, 인코포레이티드 | 질환 치료용 요법 |
| US20120064159A1 (en) * | 2009-05-28 | 2012-03-15 | Aptapharma, Inc. | Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen |
| GB201003731D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
| US20120244221A1 (en) * | 2010-07-08 | 2012-09-27 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US20120010294A1 (en) * | 2010-07-08 | 2012-01-12 | Dill David A | Compositions and methods for the inhibition of muscle contraction |
-
2013
- 2013-03-13 BR BR112014020271A patent/BR112014020271A8/pt not_active Application Discontinuation
- 2013-03-13 NZ NZ630471A patent/NZ630471A/en not_active IP Right Cessation
- 2013-03-13 RU RU2014142025A patent/RU2669565C2/ru not_active IP Right Cessation
- 2013-03-13 SG SG11201500408VA patent/SG11201500408VA/en unknown
- 2013-03-13 MX MX2014011128A patent/MX2014011128A/es unknown
- 2013-03-13 MY MYPI2014702434A patent/MY174090A/en unknown
- 2013-03-13 JP JP2015501754A patent/JP2015510928A/ja active Pending
- 2013-03-13 NZ NZ714288A patent/NZ714288A/en not_active IP Right Cessation
- 2013-03-13 CN CN201380015062.3A patent/CN104302284A/zh active Pending
- 2013-03-13 EP EP13763764.1A patent/EP2827852A4/en not_active Withdrawn
- 2013-03-13 NZ NZ712594A patent/NZ712594A/en not_active IP Right Cessation
- 2013-03-13 CN CN201710373440.5A patent/CN107157991A/zh active Pending
- 2013-03-13 AU AU2013235518A patent/AU2013235518B2/en not_active Ceased
- 2013-03-13 NZ NZ718163A patent/NZ718163A/en not_active IP Right Cessation
- 2013-03-13 WO PCT/US2013/030901 patent/WO2013142197A1/en not_active Ceased
- 2013-03-13 CA CA2866853A patent/CA2866853A1/en not_active Abandoned
- 2013-03-13 KR KR1020147029163A patent/KR20140134333A/ko not_active Ceased
- 2013-03-14 RU RU2014142066/15A patent/RU2599017C2/ru not_active IP Right Cessation
- 2013-03-14 JP JP2015501785A patent/JP2015510936A/ja active Pending
- 2013-03-14 NZ NZ628079A patent/NZ628079A/en not_active IP Right Cessation
- 2013-03-14 RU RU2016133305A patent/RU2016133305A/ru not_active Application Discontinuation
- 2013-03-14 EP EP13763665.0A patent/EP2827851A4/en not_active Withdrawn
- 2013-03-14 MY MYPI2014702174A patent/MY175764A/en unknown
- 2013-03-14 MX MX2014011129A patent/MX2014011129A/es unknown
- 2013-03-14 CN CN201380015025.2A patent/CN104321056A/zh active Pending
- 2013-03-14 HK HK15105034.0A patent/HK1204553A1/xx unknown
- 2013-03-14 SG SG11201500409SA patent/SG11201500409SA/en unknown
- 2013-03-14 KR KR1020187038194A patent/KR20190003840A/ko not_active Ceased
- 2013-03-14 KR KR1020177002422A patent/KR20170015537A/ko not_active Ceased
- 2013-03-14 NZ NZ714662A patent/NZ714662A/en not_active IP Right Cessation
- 2013-03-14 CA CA2866755A patent/CA2866755A1/en not_active Abandoned
- 2013-03-14 BR BR112014020113A patent/BR112014020113A8/pt not_active Application Discontinuation
- 2013-03-14 WO PCT/US2013/031617 patent/WO2013142274A1/en not_active Ceased
- 2013-03-14 KR KR20147024604A patent/KR20140134284A/ko not_active Ceased
- 2013-03-14 AU AU2013235507A patent/AU2013235507B2/en not_active Ceased
- 2013-03-14 CN CN201711086139.2A patent/CN107789626A/zh active Pending
-
2014
- 2014-08-11 ZA ZA2014/05862A patent/ZA201405862B/en unknown
- 2014-08-21 ZA ZA2014/06146A patent/ZA201406146B/en unknown
- 2014-09-17 MX MX2019008817A patent/MX2019008817A/es unknown
-
2015
- 2015-05-27 HK HK18110965.0A patent/HK1251469A1/zh unknown
-
2016
- 2016-05-04 JP JP2016092868A patent/JP2016172752A/ja active Pending
-
2017
- 2017-05-11 AU AU2017203139A patent/AU2017203139B2/en not_active Ceased
- 2017-05-15 AU AU2017203246A patent/AU2017203246B2/en not_active Ceased
- 2017-09-20 JP JP2017179685A patent/JP2018024693A/ja active Pending
-
2018
- 2018-03-10 HK HK18103371.3A patent/HK1243921A1/zh unknown
- 2018-05-15 JP JP2018093416A patent/JP2018138602A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015510928A5 (enExample) | ||
| RU2014142025A (ru) | Препарат длительного высвобождения для снижения частоты мочеиспускания и способ его применения | |
| ES2409069B2 (es) | Uso de aglutinantes para fabricar formulaciones estables al almacenamiento | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| JP2015523407A5 (enExample) | ||
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| JP2012255026A5 (enExample) | ||
| AR122580A2 (es) | Forma de dosificación de doxilamina y piridoxina y/o sus metabolitos o sales | |
| JP2015503583A5 (enExample) | ||
| CL2014002754A1 (es) | Forma de dosis de liberación controlada solida que comprende un nucleo con una primera porcion de un analgesico opioide y una cubierta que encierra el nucleo y comprende una segunda porcion del analgesico opioide; metodo de preparacion; uso en el tratamiento del dolor. (divisional de solicitud n°1450-2014). | |
| JP2008505857A5 (enExample) | ||
| JP2013509429A5 (enExample) | ||
| CL2016002132A1 (es) | Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo. | |
| JP2014521735A5 (enExample) | ||
| JP2015038135A5 (enExample) | ||
| JP2013231087A5 (enExample) | ||
| EA201071204A1 (ru) | Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности | |
| ECSP11011289A (es) | Formulaciones galénicas de compuestos orgánicos | |
| UA117260C2 (uk) | Лікарський препарат з відстроченим вивільненням | |
| JP2013541583A5 (enExample) | ||
| MY173582A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| JP2016532516A5 (enExample) | ||
| WO2015038552A3 (en) | Aspirin formulation for increased efficacy | |
| JP2013166781A5 (enExample) | ||
| WO2014107730A3 (en) | Use of fatty acid niacin conjugates for treating diseases |